|
[1] Surani M A, Barton S C, Norris M L. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature, 1984, 308(5959):548-550.
[2] McGrath J, Solter D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell, 1984, 37(1):179-183.
[3] Barlow D P. Genomic imprinting: a mammalian epigenetic discovery model. Annu Rev Genet, 2011, 45:379-403.
[4] Fedoriw A, Mugford J, Magnuson T. Genomic imprinting and epigenetic control of development. Cold Spring Harb Perspect Biol, 2012, 4(7):a008136.
[5] Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res, 2012, 22(9):1775-1789.
[6] Wilusz J E, Sunwoo H, Spector D L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 2009, 23(13):1494-1504.
[7] Pauli A, Rinn J L, Schier A F. Non-coding RNAs as regulators of embryogenesis. Nat Rev Genet, 2011, 12(2):136-149.
[8] Collins F S,Lander E S,Rogers J, et al. Finishing the euchromatic sequence of the human genome. Nature, 2004, 431(7011):931-945.
[9] Kung J T, Colognori D, Lee J T, et al. Long Noncoding RNAs: Past, Present, and Future. Genetics, 2013, 193(3):651-669.
[10] Fire A, Xu S, Montgomery M K, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998, 391(6669):806-811.
[11] Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75(5):843-854.
[12] Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature, 2002, 420(6915):563-573.
[13] Lee J T, Bartolomei M S. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell, 2013, 152(6):1308-1323.
[14] Kornienko A E, Guenzl P M, Barlow D P, et al. Gene regulation by the act of long non-coding RNA transcription. BMC Biol, 2013, 11:59.
[15] Bumgarner S L, Dowell R D, Grisafi P, et al. Toggle involving cis-interfering noncoding RNAs controls variegated gene expression in yeast. Proc Natl Acad Sci U S A. 2009, 106(43):18321-18326.
[16] Lee J S, Shilatifard A. A site to remember: H3K36 methylation a mark for histone deacetylation. Mutat Res, 2007, 618(1-2):130-134.
[17] Bannister A J, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res, 2011, 21(3):381-395.
[18] Brookes E, Pombo A. Modifications of RNA polymerase II are pivotal in regulating gene expression states. EMBO Rep, 2009, 10(11):1213-1219.
[19] Ehrensberger A H, Svejstrup J Q. Reprogramming chromatin. Crit Rev Biochem Mol Biol, 2012, 47(5): 464-482.
[20] van Werven F J, Neuert G, Hendrick N, et al. Transcription of two long noncoding RNAs mediates mating-type control of gameto genesis in budding yeast. Cell, 2012, 150(6):1170-1181.
[21] Houseley J, Rubbi L, Grunstein M, et al. ncRNA modulates histone modification and mRNA induction in the yeast GAL gene cluster. Mol Cell, 2008, 32(5):685-695.
[22] Li B, Carey M, Workman J L. The role of chromatin during transcription. Cell, 2007, 128(4):707-719.
[23] Deaton A M, Bird A. CpG islands and the regulation of transcription. Genes Dev, 2011, 25(10):1010-1022.
[24] Tufarelli C, Stanley J A, Garrick D, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet, 2003, 34(2):157-165.
[25] Hobson D J, Wei W, Steinmetz L M, et al. RNA polymerase II collision interrupts convergent transcription. Mol Cell, 2012, 48(3):365-374.
[26] 程婷婷, 徐刚毅. 基因印记的功能及应用. 生命的化学, 2007, 27(5):402-404. Chen T T, Xu G Y. Functions and applications of genomic imprinting. Chemistry of Life, 2007, 27(5):402-404.
[27] Dykens E M, Lee E, Roof E. Prader-Willi syndrome and autism spectrum disorders: an evolving story. J Neurodev Disord, 2011, 3(3):225-237
[28] Cassidy S B, Schwartz S, Miller J L, et al. Prader-Willi syndrome. Genet Med, 2012, 14(1):10-26.
[29] 谢小虎, 周文华. 基因组印记与疾病研究进展. 生命科学, 2008, 20(3):438-441. Xie X H, Zhou W H. Genomic imprinting and disease. Chinese Bulletin of Life Sciences, 2008, 20(3):438-441.
[30] Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science, 2006, 311(5758):230-232.
[31] Zhang Z, Falaleeva M, Agranat-Tamir L, et al. The 5' untranslated region of the serotonin receptor 2C pre-mRNA generates miRNAs and is expressed in non-neuronal cells. Exp Brain Res, 2013, 230(4):387-394.
[32] Falaleeva M, Sulsona C R, Zielke H R, et al. Molecular characterization of a patient presumed to have prader-willi syndrome. Clin Med Insights Case Rep, 2013, 6:79-86.
[33] Weksberg R, Shen D R, Fei Y L, et al. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiede-mann syndrome. Nat Genet, 1993, 5(2):143-150.
[34] Ogawa O, Eccles M R, Szeto J, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms’tumour. Nature, 1993, 362(6422):749-751.
[35] Rainier S, Johnson L A, Dobry C J, et al. Relaxation of imprinted genes in human cancer. Nature, 1993, 362:747-749.
[36] Weksberg R, Shuman C, Smith A C. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet, 2005, 137C(1):12-23.
[37] Hark A T, Tilghman S M. Chromatin conformation of the H19 epigenetic mark. Hum Mol Genet, 1998, 7(12):1979-1985.
[38] Bliek J, Maas S M, Ruijter J M, et al. Increased tumour risks for BWS patients correlates with aberrant H19 and not KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Gen, 2001, 10(5):467-476.
[39] Li M, Squire J, Shuman C, et al. Imprinting status of 11p15 genes in Beck-with-Wiedemann syndrome patients with CDKN1C mutations. Genomics, 2001, 74(3):370-376.
[40] Sun F L, Dean W L, Kelsey G, et al. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature, 1997, 389(6653):809-815.
[41] Sparago A, Cerrato F, Vernucci M, et al. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiede-mann syndrome. Nat Genet, 2004, 36(9):958-960.
[42] Lee M P, Hu R J, Johnson L A, et al. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rear-rangements. Nat Genet, 1997, 15(2):181-185.
[43] Pandey R R, Mondal T, Mohammad F, et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell, 2008; 32(2):232-246.
[44] Terranova R, Yokobayashi S, Stadler M B, et al. Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos. Dev Cell, 2008, 15(5):668-679.
[45] Umlauf D, Goto Y, Cao R, et al. Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat Genet, 2004, 36(12):1296-1300.
[46] Lewis A, Mitsuya K, Umlauf D, et al. Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation. Nat Genet, 2004, 36(12):1291-1295.
[47] Kanduri C. Kcnq1ot1 A chromatin regulatory RNA. Semin Cell Dev Biol, 2011, 22(4):343-350.
[48] Weksberg R, Shuman C, Smith A C. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet, 2005, 137C(1):12-23.
[49] Jiang J, Jing Y, Cost G J, et al. Translating dosage compensation to trisomy 21. Nature, 2013, 500(7462):296-300.
|
